[China Eastern Airlinesrporation Limitedte October 30, 2013 By Hon A joint stock limitedmpanyorporated in the Peoples Republic of China with limited liability) ( (Stockde: 00670) D QUARTERLY REPORT 2013 THIR The financial statements of thempany for the third quarter of 2013 were not audited, and were prepared in accordance with the Accounting Regulations.]
[Item 5.07 Submission of Matters to a Vote of Security Holders On October 25, 2013,ystar Bio-Pharmaceuticalmpany (thempany) held its Annual Meeting of Shareholders at thempanys executive officers in Xian, Shaanxi Province, China. Set forth below are the matters voted upon at the meeting and the voting results:]
[CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered (1) (2) Amount of shares (1) Proposed maximum (2) Proposed Maximum (4) Amount Of Class B Ordinary shares, par value US$0.001 per share (2) (3) 38,332,950 US$4.67 US$178,877,100 US$23,989 (1) (2) (3) American depositary shares issuable upon deposit of the Class B ordinary shares registered hereby have] [Consent of Independent Registered Public Accounting Firm We consent to the reference to our firm under the caption Experts and to the use of our report dated April 12, 2013, in Amendment No. 6 to the Registration Statement (Form F-1 No. 333-191459) and related Prospectus of Qunar Cayman Islands Limited for the registration of its ordinary shares. Beijing, Peoples Republic]
[Item 8.01. Other Events. On April 30, 2013,ChinaNet Onlines, (the "Company")received a letter fromThe NASDAQ Stock Market ("NASDAQ")stating that for 30nsecutive businessys immediately preceding thete of the letter thempany'smmon stock did not maintain a minimum closing bid price of $1.00 per share ("Minimum Bid Price Requirement") required by NASDAQ Listing Rule 5450(a)(1). Thempany was provided]
[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif} .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif} .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif} .FormText {font-size: x-small; font-family: arial, helvetica, sans-serif} .SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif} .FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold} .FormName {font-size: large; font-family: arial, helvetica, sans-serif;]
[Contact: WSP Holdings Limited Compass Investor Relations Ms. Judy Zhu, IR Director Ms. Elaine Ketchmere, Partner Phone: +86-510-8536-0401 Phone: +1-310-528-3031 (Los Angeles) E-mail: info@wsphl.com E-mail: eketchmere@compass-ir.com http://www.wsphl.com WSP Holdings Announces Update on Filing of Annual Report on 20-F WUXI, China, October 30, 2013 WSP Holdings Limited (NYSE: WH) (WSP Holdings or the Company), a Chinese manufacturer of API (American] [WSP HOLDINGS LIMITED No. 38 Zhujiang Road Form 20-F x Form 40-F o o o WSP HOLDINGS LIMITED Then Choon Hoi Chief Financial Officer]
[Registration No. 333-191283 AMENDMENT No.1 to FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Kandi Technologies Group, Inc. Delaware 90-0363723 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification Number) Jinhua City Industrial Zone Jinhua, Zhejiang Province Peoples Republic of China Post Code 321016 (86 - 579) 82239856 Hu Xiaoming, Chief Executive Officer Kandi Technologies Group,] [Albany Atlanta Brussels Denver Los Angeles Miami New York THOMAS WARDELL mckennalong.com Northern Virginia Orange County Rancho Santa Fe San Diego San Francisco Seoul EMAIL ADDRESS October 30, 2013 Board of Directors Re: Amendment No.1 to Primary Registration Statement on Form S-3 Gentlemen: Company Registration Statement Commission Act Common Stock Shares We have acted as legal counsel to Kandi Technologies] [ALBERT WONG & CO. ALBERT WONG B.Soc., Sc., ACA., LL.B., C.P.A.(Practising) CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors Albert Wong & Co.]
[Subject tompletion,ted October 30, 2013 PROSPECTUS $100,000,000 CHINARD BLOODRPORATION Ordinary Shares The securitiesvered by this prospectus may be offered and sold from time to time in one or more offerings, which may be through one or more underwriters, dealers andents, or directly to the purchasers. The names of any underwriters, dealers orents, if any, will] [Three Months Ended Year Ended March 31, 2013 2013 2012 2011 2010 2009 Ratio of earnings to fixed charges 2.5 3.2 27.6 30.6 19.2 30.1 Earnings: Three Months Ended Year Ended March 31, RMB000 2013 2013 2012 2011 2010 2009ome beforeome tax 44,432 158,185 151,599 132,142 79,663 42,299d: Fixed charges] [Consent of Independent Registered Public Accounting Firm The Board of Directors Chinard Bloodrporation Wensent to the use of our reportsted July 31, 2013, with respect to thensolidated balance sheets of Chinard Bloodrporation and subsidiaries of March 31, 2012 and 2013, and the relatednsolidated statements ofmprehensiveome, changes in equity, andsh flows for each of the years]
[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif} .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif} .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif} .FormText {font-size: x-small; font-family: arial, helvetica, sans-serif} .SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif} .FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold} .FormName {font-size: large; font-family: arial, helvetica, sans-serif;]
